BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34323425)

  • 41. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
    Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
    Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
    Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
    BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
    Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
    Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
    Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells.
    Jung YY; Baek SH; Narula AS; Namjoshi OA; Blough BE; Ahn KS
    Life Sci; 2021 Nov; 284():119893. PubMed ID: 34454947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reciprocal positive regulation between Cx26 and PI3K/Akt pathway confers acquired gefitinib resistance in NSCLC cells via GJIC-independent induction of EMT.
    Yang J; Qin G; Luo M; Chen J; Zhang Q; Li L; Pan L; Qin S
    Cell Death Dis; 2015 Jul; 6(7):e1829. PubMed ID: 26203858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis.
    Sun BS; You J; Li Y; Zhang ZF; Wang CL
    Chin Med J (Engl); 2013; 126(9):1683-8. PubMed ID: 23652051
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteopontin facilitates tumor metastasis by regulating epithelial-mesenchymal plasticity.
    Jia R; Liang Y; Chen R; Liu G; Wang H; Tang M; Zhou X; Wang H; Yang Y; Wei H; Li B; Song Y; Zhao J
    Cell Death Dis; 2016 Dec; 7(12):e2564. PubMed ID: 28032860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. OPN-a Splicing Variant Expression in Non-small Cell Lung Cancer and its Effects on the Bone Metastatic Abilities of Lung Cancer Cells
    Hao C; Cui Y; Hu MU; Zhi X; Zhang L; Li W; Wu W; Cheng S; Jiang WG
    Anticancer Res; 2017 May; 37(5):2245-2254. PubMed ID: 28476789
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
    Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
    Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
    [TBL] [Abstract][Full Text] [Related]  

  • 53. BENC-511, a novel PI3K inhibitor, suppresses metastasis of non-small cell lung cancer cells by modulating β-catenin/ZEB1 regulatory loop.
    Zhang Q; Zhou L; Guan Y; Cheng Y; Han X
    Chem Biol Interact; 2018 Oct; 294():18-27. PubMed ID: 30125547
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer.
    Yang S; Liu Y; Li MY; Ng CSH; Yang SL; Wang S; Zou C; Dong Y; Du J; Long X; Liu LZ; Wan IYP; Mok T; Underwood MJ; Chen GG
    Mol Cancer; 2017 Jul; 16(1):124. PubMed ID: 28716029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1.
    Cao J; Li J; Sun L; Qin T; Xiao Y; Chen K; Qian W; Duan W; Lei J; Ma J; Ma Q; Han L
    Mol Oncol; 2019 Feb; 13(2):228-245. PubMed ID: 30367545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The expression of galectin-3 and osteopontin in occult metastasis of non-small cell lung cancer].
    Liang Y; Li H; Hou SC; Hu B; Miao JB; Li T; You B; Yu LX; Wang L; Chen QR; Chen X
    Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(14):1061-3. PubMed ID: 19781269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
    Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2.
    Jin JJ; Liu YH; Si JM; Ni R; Wang J
    Int J Biochem Cell Biol; 2018 Feb; 95():113-120. PubMed ID: 29275213
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Sun M; Liu XH; Lu KH; Nie FQ; Xia R; Kong R; Yang JS; Xu TP; Liu YW; Zou YF; Lu BB; Yin R; Zhang EB; Xu L; De W; Wang ZX
    Cell Death Dis; 2014 Jun; 5(6):e1298. PubMed ID: 24967960
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.